Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $393.4000 (0.22%) ($390.5000 - $394.7500) on Thu. Sep. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.84% (three month average) | RSI | 31 | Latest Price | $393.4000(0.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -0.92% in a week (0% probabilities). VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) TIP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.92% (StdDev 1.84%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $410.09 | 5 Day Moving Average | $396.7(-0.83%) | 10 Day Moving Average | $402.79(-2.33%) | 20 Day Moving Average | $410.09(-4.07%) | To recent high | -10.9% | To recent low | 18.8% | Market Cap | $41.712b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |